THE INSTITUTE OF CANCER RESEARCH; ROYAL CANCER HOSPITAL
发明人:
ASHWORTH, Alan,LORD, Christopher James,BROUGH, Rachel,FRANKUM, Jessica
申请号：
GBGB2012/051290
公开号：
WO2012/168721A1
申请日:
2012.06.08
申请国别(地区):
WO
年份:
2012
代理人:
摘要：
The use of inhibitors of mitotic kinases, such as TTK protein kinase, is described for use in the treatment of cancers which are characterized as Phosphatase and Tensin Homolog (PTEN) mutated or deficient cancers.Linvention concerne lutilisation dinhibiteurs de kinases mitotiques, telles que la protéine kinase TTK, pour traiter des cancers caractérisés comme des cancers à déficience ou à mutation du gène PTEN.
